Thus, an anatomical hallmark of FAS (microphthalmia) is present even in the first trimester, and this has allowed us to use eye diameter to validate the prognostic value of putative biomarkers for FAS, such as FB-E MBP levels (see below). The gene discussed is FAS; the disease is microphthalmia.